PT  - JOURNAL ARTICLE
AU  - PHILIPPE DIEUDE
AU  - KAREN DAWIDOWICZ
AU  - MICKAËL GUEDJ
AU  - YONA LEGRAIN
AU  - JULIEN WIPFF
AU  - ERIC HACHULLA
AU  - ELISABETH DIOT
AU  - JEAN SIBILIA
AU  - LUC MOUTHON
AU  - JEAN CABANE
AU  - ZAHIR AMOURA
AU  - JEAN-LUC CRAKOWSKI
AU  - PATRICK CARPENTIER
AU  - JEROME AVOUAC
AU  - OLIVIER MEYER
AU  - ANDRE KAHAN
AU  - CATHERINE BOILEAU
AU  - YANNICK ALLANORE
TI  - Phenotype-Haplotype Correlation of <em>IRF5</em> in Systemic Sclerosis: Role of 2 Haplotypes in Disease Severity
AID  - 10.3899/jrheum.091163
DP  - 2010 May 01
TA  - The Journal of Rheumatology
PG  - 987--992
VI  - 37
IP  - 5
4099  - http://www.jrheum.org/content/37/5/987.short
4100  - http://www.jrheum.org/content/37/5/987.full
SO  - J Rheumatol2010 May 01; 37
AB  - Objective. Identification of an association between IRF5 rs2004640 and systemic sclerosis (SSc) has highlighted a key role for type 1 interferon (IFN). Additional functional IRF5 variants have been identified as autoimmune susceptibility factors. Our aim was to investigate whether IRF5 haplotypes confer susceptibility to SSc, and to perform genotype haplotype-phenotype correlation analyses. Methods. We genotyped IRF5 rs377385, rs2004640, and rs10954213 in 1623 individuals of French European Caucasian origin. SSc patient subphenotypes were analyzed according to cutaneous subsets and for SSc-related pulmonary fibrosis. Results. Case-control studies of single markers revealed an association between IRF5 rs3757385, rs2004640, and rs10954213 variants and SSc. We identified an IRF5 risk haplotype “R” (padj = 0.024, OR 1.23, 95% CI 1.07–1.40) and a mirrored protective haplotype “P” (padj = 8.8 × 10−3, OR 0.78, 95% CI 0.68–0.90) for SSc susceptibility. Genotype-phenotype correlation analyses failed to detect any association with a single marker. By contrast, phenotype-haplotype correlation analysis was able to detect intra-cohort association and to discriminate SSc patients with from those without the following clinical traits: “R” and/or “P” haplotypes identified diffuse cutaneous SSc (p = 0.0081) and fibrosing alveolitis (p = 0.018). Conclusion. IRF5 haplotypes are more informative than single markers, suggesting that they could be helpful for risk stratification of SSc patients. Our study provides further evidence of a key role of IRF5 in SSc severity.